RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Quest Diagnostics Stock

Quest Diagnostics ROE 2024

Quest Diagnostics ROE

0.13

Ticker

DGX

ISIN

US74834L1008

WKN

904533

In 2024, Quest Diagnostics's return on equity (ROE) was 0.13, a -15.69% increase from the 0.16 ROE in the previous year.

Quest Diagnostics Aktienanalyse

What does Quest Diagnostics do?

Quest Diagnostics Inc is a leading company in the field of diagnostic information and services, headquartered in New Jersey, USA. The company is dedicated to providing medical professionals and patients worldwide with fast, accurate, and preventive diagnostic tests. The history of Quest Diagnostics dates back to 1967 when the company MetPath was founded by Dr. Paul A. Brown. In the following years, several acquisitions and mergers took place, eventually leading to the establishment of Quest Diagnostics in 1996. Since then, the company has continuously evolved and now offers a wide range of diagnostic tests and services, ranging from the analysis of blood samples to genetic testing procedures. The business model of Quest Diagnostics is based on providing high-quality and individualized information to medical professionals and patients to assist in the diagnosis, treatment, and cure of their health problems. The company works closely with doctors, hospitals, and other medical institutions worldwide to offer a comprehensive range of innovative diagnostic products, procedures, and technologies tailored to meet specific needs. Quest Diagnostics offers a wide range of services, ranging from laboratory testing to data management and clinical trials. The company has various business segments, including the Diagnostic Services business, the Medical Research Services business, and the Information Services business. In the field of Diagnostic Services, Quest Diagnostics offers a broad spectrum of laboratory tests divided into different categories such as cancer diagnostics, cardiology, endocrinology, immunology, and infectious diseases. The company also provides a variety of genetic tests that enable precise analysis of individual genomes, supporting the diagnosis and treatment of various genetic disorders. In the medical research field, Quest Diagnostics provides a range of services to support clinical trials and drug development. The company also offers a wide range of laboratory tests used in biomedical research to improve people's health and well-being. The Information Services business segment of Quest Diagnostics mainly focuses on providing innovative solutions in the field of data management and information technology. This includes the development of software tools that can be used for the analysis and management of health data. Additionally, the company offers consulting services to help medical professionals address challenges related to information processing and data integration. Quest Diagnostics is a company based on innovation and knowledge that collaborates closely with doctors, clinics, and other medical facilities worldwide to offer a relatively comprehensive range of need-specific diagnostic products, procedures, and solutions. From cancer diagnostics to genomic diagnostics, from clinical trials to information and data services, and a wide range of molecular diagnostic tests and laboratory analyses, Quest Diagnostics provides top-notch solutions for optimal patient care, contributing to the goal of improving global healthcare for people worldwide. Quest Diagnostics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Quest Diagnostics's Return on Equity (ROE)

Quest Diagnostics's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Quest Diagnostics's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Quest Diagnostics's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Quest Diagnostics’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Quest Diagnostics stock

What is the ROE (Return on Equity) of Quest Diagnostics this year?

The ROE of Quest Diagnostics this year is 0.13 undefined.

How has the Return on Equity (ROE) of Quest Diagnostics developed compared to the previous year?

The ROE of Quest Diagnostics has increased by -15.69% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Quest Diagnostics?

A high ROE indicates that Quest Diagnostics generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Quest Diagnostics?

A low ROE can indicate that Quest Diagnostics is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Quest Diagnostics affect the company?

A change in ROE (Return on Equity) of Quest Diagnostics can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Quest Diagnostics?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Quest Diagnostics?

Some factors that can influence Quest Diagnostics's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Quest Diagnostics pay?

Over the past 12 months, Quest Diagnostics paid a dividend of 2.79 USD . This corresponds to a dividend yield of about 1.8 %. For the coming 12 months, Quest Diagnostics is expected to pay a dividend of 3.12 USD.

What is the dividend yield of Quest Diagnostics?

The current dividend yield of Quest Diagnostics is 1.8 %.

When does Quest Diagnostics pay dividends?

Quest Diagnostics pays a quarterly dividend. This is distributed in the months of February, May, August, November.

How secure is the dividend of Quest Diagnostics?

Quest Diagnostics paid dividends every year for the past 25 years.

What is the dividend of Quest Diagnostics?

For the upcoming 12 months, dividends amounting to 3.12 USD are expected. This corresponds to a dividend yield of 2.01 %.

In which sector is Quest Diagnostics located?

Quest Diagnostics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Quest Diagnostics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Quest Diagnostics from 10/21/2024 amounting to 0.75 USD, you needed to have the stock in your portfolio before the ex-date on 10/4/2024.

When did Quest Diagnostics pay the last dividend?

The last dividend was paid out on 10/21/2024.

What was the dividend of Quest Diagnostics in the year 2023?

In the year 2023, Quest Diagnostics distributed 2.6 USD as dividends.

In which currency does Quest Diagnostics pay out the dividend?

The dividends of Quest Diagnostics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Quest Diagnostics

Our stock analysis for Quest Diagnostics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Quest Diagnostics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.